beta-(4-hydroxyphenyl)ethyl-4-O-E-caffeoyl-O-[beta-D-apiofuranosyl-(1->2)]-beta-D-glucopyranoside

Term ID

CHEBI:68340

Synonyms

2-(4-hydroxyphenyl)ethyl 2-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl]-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside

Definition

A phenylethanoid that is the 4-O-E-caffeoyl-O-[beta-D-apiofuranosyl-(1->2)]-beta-D-glucopyranosyl derivative of 4-(2-hydroxyethyl)phenol. Isolated from Lepisorus contortus, it exhibits inhibitory activities against aromatase and NF-kappaB.

References

PMID:21261296

Ontology

ChEBI ( EBI )

Relationships

is a type of: alkyl caffeate ester beta-D-glucoside phenylethanoid

alkyl caffeate ester beta-D-glucoside phenylethanoid Show first 5 Terms
has_role: EC 1.14.14.14 (aromatase) inhibitor NF-kappaB inhibitor plant metabolite

EC 1.14.14.14 (aromatase) inhibitor NF-kappaB inhibitor plant metabolite Show first 5 Terms

Phenotype

Phenotype resulting from beta-(4-hydroxyphenyl)ethyl-4-O-E-caffeoyl-O-[beta-D-apiofuranosyl-(1->2)]-beta-D-glucopyranoside

Phenotype where environments contain beta-(4-hydroxyphenyl)ethyl-4-O-E-caffeoyl-O-[beta-D-apiofuranosyl-(1->2)]-beta-D-glucopyranoside

Phenotype modified by environments containing beta-(4-hydroxyphenyl)ethyl-4-O-E-caffeoyl-O-[beta-D-apiofuranosyl-(1->2)]-beta-D-glucopyranoside

Human Disease Model